1-5 of 5
Nidal Boulos
Close
Sort by
Journal Articles

Precision Medicine for Sickle Cell Disease through Whole Genome Sequencing

Evadnie Rampersaud, PhD, Lance E. Palmer, PhD, Jane S. Hankins, MD MS, Vivien A Sheehan, MD PhD, Wenjian Bi, PhD, Heather Mulder, BS, Guolian Kang, PhD, Jeremie H. Estepp, MD, Shuoguo Wang, PhD, Andrew Thrasher, PhD, Martha Villavicencio, PhD, Jason R Hodges, PhD MA, Wenan Chen, PhD, Ti-Cheng Chang, PhD, Yong Cheng, PhD, Michael Rusch, BS, Yadav Sapkota, PhD, Akshay Sharma, MBBS, Pavel Sumazin, PhD, Xing Tang, PhD, Amanda M. Brandow, DO, MS, Shawn Levy, Nidal Boulos, PhD, Celeste Rosencrance, BS, Donald Yergeau, PhD, Jeffrey Lebensburger, DO, MSPH, Winfred Wang, MD, Yutaka Yasui, PhD, John Easton, PhD, Michael R. DeBaun, MD, James R. Downing, MD, Jinghui Zhang, Gang Wu, PhD, Mitchell J. Weiss, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3641.
https://doi.org/10.1182/blood-2018-99-117606
Published: 2018
Journal Articles

Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome–positive acute lymphoblastic leukemia

Nidal Boulos, Heather L. Mulder, Christopher R. Calabrese, Jeffrey B. Morrison, Jerold E. Rehg, Mary V. Relling, Charles J. Sherr, Richard T. Williams
Journal: Blood
Blood (2011) 117 (13): 3585–3595.
https://doi.org/10.1182/blood-2010-08-301267
Published: 2011
Includes: Supplemental data
Journal Articles

The Role of Dominant-Negative IKAROS Mutations In the Pathogenesis and Treatment Responsiveness of BCR-ABL1 positive Acute Lymphoblastic Leukemia

J. Racquel Collins-Underwood, PhD, Nidal Boulos, PhD, Debbie Payne-Turner, Shann-Ching Chen, Ph.D., Richard Williams, MD, PhD, Charles Mullighan, MBBS, MD, FRACP, FRCPA, MSc
Journal: Blood
Blood (2010) 116 (21): 540.
https://doi.org/10.1182/blood.V116.21.540.540
Published: 2010
Journal Articles

Acquired Bcr-Abl Kinase Domain Mutations Are Not Responsible for Persistence of Dasatinib-Refractory Disease in Murine Ph+ ALL

Nidal Boulos, PhD, Charles J. Sherr, MD, PhD, Richard T Williams, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2924.
https://doi.org/10.1182/blood.V112.11.2924.2924
Published: 2008
Journal Articles

Cytokine-Dependent Imatinib Resistance in Mouse Bcr-Abl(+), Arf -Null Lymphoblastic Leukemia.

Richard T. Williams, MD, PhD, Willem den Besten, PhD, Nidal Boulos, PhD, Charles J. Sherr, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2632.
https://doi.org/10.1182/blood.V110.11.2632.2632
Published: 2007